Evercore (EVR), What Is Behind The Fresh Attention?

Evercore (EVR) stock drew fresh attention after the company hired John Pissanos as a Senior Managing Director in its London based healthcare investment banking group, with a focus on life science tools, diagnostics and medtech.

Evercore shares have eased over the past quarter, with a 90 day share price return of 12.42% and a year to date share price return of 15.19%. The 3 year total shareholder return of 121.69% and 5 year total shareholder return of 134.29% still point to strong long term compounding, so the appointment of John Pissanos may be viewed as a potential catalyst as investors reassess growth prospects in healthcare advisory.

Scan the market for other financial stocks pursuing similar advisory growth stories by checking our hand picked 19 high quality undiscovered gems that are aligned with Evercore's evolving healthcare focus.

Evercore appears to be a high quality advisory business with a deeper push into healthcare following the Pissanos hire. The key issue now is more straightforward: Does the current share price still leave enough value on the table?

Most Popular Narrative: 18.1% Undervalued

Evercore last closed at $297.92 while the most followed narrative pegs fair value at $363.90, which frames the Pissanos hire within a broader undervaluation story.

The ongoing globalization of capital markets and an accelerating trend in cross-border M&A activity are providing an increasingly fertile environment for independent, conflict-free advisors like Evercore. The firm's continued expansion into key international markets, as evidenced by new offices and hiring in EMEA (France, Spain, Italy, Dubai, UK), positions it to capture an increasing share of growing advisory fee pools and drive top-line revenue over the long term.

Read the complete narrative.

Want to see how this expansion story supports that higher fair value for Evercore? The narrative hinges on modest revenue growth, firm margins and a richer future earnings multiple. The interesting part is how those ingredients are combined and discounted at just over 8%. The full breakdown shows exactly which assumptions have to hold for that valuation to stack up.

Result: Fair Value of $363.90 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Evercore still faces pressure from rising non compensation expenses and reliance on cyclical M&A activity, which could quickly weaken the current undervaluation case.

Find out about the key risks to this Evercore narrative.

Another View on Evercore's Valuation

The earlier narrative framed Evercore as about 18.1% undervalued based on a fair value estimate of $363.90. A different lens that focuses on the P/E ratio tells a more cautious story. Evercore trades on a P/E of 15.4x while the fair ratio is 13x. That implies the share price could need to move closer to this fair ratio if sentiment cools.

At the same time, Evercore's 15.4x P/E is far below the peer average of 27.8x and the wider US Capital Markets industry at 39.7x. So the stock looks expensive against the fair ratio but comparatively cheap against peers. For investors, the question is which reference point will matter most when the next set of results lands.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

After weighing both the bullish and cautious takes on Evercore, it can be useful to move quickly and review the numbers for yourself. To see how the positives and negatives balance out in one place, take a look at the 3 key rewards and 1 important warning sign.

Looking for more Evercore style investment ideas?

If the Evercore story has you thinking about what else might be worth a closer look, use the Simply Wall Street Screener today and avoid leaving opportunities on the table.

• Target companies with strong fundamentals and appealing entry points by scanning the market through the 47 high quality undervalued stocks.
• Strengthen your income potential by focusing on reliable cash payouts using the 11 dividend fortresses.
• Prioritise resilience and capital preservation by concentrating on stocks highlighted in the 81 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com